Effects of Virologic Response to Treatment on Short- and Long-term Outcomes of Patients With Chronic HBV Infection and Decompensated Cirrhosis

Little is known about the effects of antiviral therapy on short- and long-term survival of patients with hepatitis B virus (HBV)-related decompensated cirrhosis. We aimed to determine whether a maintained virologic response (MVR, defined as persistent undetectable HBV DNA during therapy) associates with short-term (6-month) and long-term (6–120 months) survival of patients with decompensated cirrhosis.

https://ift.tt/2I9YfuU